role of the multikinase inhibitor regorafenib in metastatic colorectal cancer
Published 10 years ago • 886 plays • Length 10:02Download video MP4
Download video MP3
Similar videos
-
8:14
optimizing treatment with regorafenib in metastic colorectal cancer
-
9:34
regorafenib in colorectal cancer
-
5:53
redos trial: optimizing regorafenib dosing in metastatic colorectal cancer
-
6:26
role of the vegf inhibitor aflibercept in metastatic colorectal cancer
-
5:25
second-line and salvage treatment of metastatic colorectal cancer
-
7:11
novel agents in the metastatic colorectal cancer refractory setting
-
11:36
panitumumab, regorafenib, and ziv-aflibercept in metastatic colorectal cancer
-
1:49
dr. george demetri describes the mechanism of action of regorafenib in gist
-
1:04
dr. randall holcombe discusses regorafenib for metastatic colorectal cancer
-
8:26
regorafenib in advanced colorectal cancer: dosing strategies
-
5:31
practical advice for using regorafenib
-
1:30
dr. nancy l. lewis discusses the correct trial for regorafenib in metastatic colorectal cancer
-
7:35
use of regorafenib in refractory mcrc
-
1:36
optimal dosing of regorafenib in colorectal cancer
-
3:53
regorafenib in colorectal cancer: optimizing the dose
-
7:46
clinical use of regorafenib in mhcc
-
4:19
the role of tas-102 in metastatic colorectal cancer
-
1:04
dr. eckhardt on the role of regorafenib in colorectal cancer
-
2:01
dr. holcombe on the progress of colorectal cancer and regorafenib